Lupin and Boehringer Ingelheim partner to develop and commercialise novel oncology drug to treat… EP News Bureau Sep 4, 2019 The partnership aims to develop Lupin’s lead MEK inhibitor compound in combination with one of Boehringer Ingelheim’s innovative…
